Pioneering PET image reconstruction technology, providing up to 2x improvement in image quality (SNR). It also delivers Q.SUV, quantitative SUV you and your patients can trust.

Did you know approximately 70% of cancer patients don’t respond to their first course of chemotherapy?

Accurately determining whether or not your patients are responding is critical, as enduring treatment is one of the toughest challenges they’ll ever face. One form of response measurement is SUV, standardized uptake value.

What if we could offer a way of measuring response to treatment, via SUV, with PET reconstruction technology you can trust, helping to provide an earlier view of how well a treatment is working? With Q.Clear, we think it’s possible. 

Benefits

  • Q.SUV

PET Reports

Related